ORGANOGENESIS HOLDINGS INC. Operating Expenses
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Operating Expenses of $94.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. operating expenses for the quarter ending 2026-06-30 was $94.75M, a 16.58% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. operating expenses for the quarter ending 2026-03-31 was $106.12M, a 6.45% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. operating expenses for the quarter ending 2025-12-31 was $162.32M, a 39.40% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. operating expenses for the quarter ending 2025-09-30 was $130.14M, a 19.46% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. operating expenses for fiscal 2025 was $519.48M, a 7.48% increase from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. operating expenses for fiscal 2024 was $483.33M, a 14.91% increase from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. operating expenses for fiscal 2023 was $420.62M, a 29.99% increase from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. operating expenses for fiscal 2022 was $323.57M, a 15.17% increase from fiscal 2021.
| Period end | Operating Expenses 1 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $94.75M 10-Q · filed 2026-08-06 | $200.87M 10-Q · filed 2026-08-06 | $363.18M derived: sum of 3 quarters · filed 2026-08-06 | $493.32M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | $106.12M 10-Q · filed 2026-05-07 | $268.44M derived: sum of 2 quarters · filed 2026-05-07 | $398.57M derived: sum of 3 quarters · filed 2026-05-07 | $512.15M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | $162.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $292.45M derived: sum of 2 quarters · filed 2026-02-26 | $406.04M derived: sum of 3 quarters · filed 2026-08-06 | $519.48M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | $130.14M 10-Q · filed 2025-11-06 | $243.72M derived: sum of 2 quarters · filed 2026-08-06 | $357.16M 10-Q · filed 2025-11-06 | $473.59M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | $113.58M 10-Q · filed 2026-08-06 | $227.02M 10-Q · filed 2026-08-06 | $343.46M derived: sum of 3 quarters · filed 2026-08-06 | $452.39M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | $113.44M 10-Q · filed 2026-05-07 | $89.72M 10-Q · filed 2025-05-08 | $229.88M derived: sum of 2 quarters · filed 2026-05-07 | $338.81M derived: sum of 3 quarters · filed 2026-05-07 | $482.94M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $116.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $225.37M derived: sum of 2 quarters · filed 2026-02-26 | $369.50M derived: sum of 3 quarters · filed 2026-02-26 | $483.33M 10-K · filed 2026-02-26 | $367.58M 10-K · filed 2025-02-27 | ||||
| 2024-09-30 | $108.94M 10-Q · filed 2025-11-06 | $82.14M 10-Q · filed 2024-11-12 | $253.06M derived: sum of 2 quarters · filed 2025-11-06 | $366.89M 10-Q · filed 2025-11-06 | $282.20M 10-Q · filed 2024-11-12 | $517.83M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $144.13M 10-Q · filed 2025-08-07 | $114.93M 10-Q · filed 2024-08-08 | $257.95M 10-Q · filed 2025-08-07 | $200.06M 10-Q · filed 2024-08-08 | $408.89M derived: sum of 3 quarters · filed 2026-02-26 | $483.58M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | $85.13M 10-Q · filed 2025-05-08 | $264.76M derived: sum of 2 quarters · filed 2026-02-26 | $339.46M derived: sum of 3 quarters · filed 2026-02-26 | $420.71M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2023-12-31 | $179.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $254.32M derived: sum of 2 quarters · filed 2026-02-26 | $335.58M derived: sum of 3 quarters · filed 2026-02-26 | $420.62M 10-K · filed 2026-02-26 | $314.13M 10-K · filed 2024-02-29 | ||||
| 2023-09-30 | $74.69M 10-Q · filed 2024-11-12 | $155.95M derived: sum of 2 quarters · filed 2024-11-12 | $240.98M 10-Q · filed 2024-11-12 | $320.67M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2023-06-30 | $81.25M 10-Q · filed 2024-08-08 | $166.29M 10-Q · filed 2024-08-08 | $245.98M derived: sum of 3 quarters · filed 2025-02-27 | $334.88M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2023-03-31 | $85.04M 10-Q · filed 2024-05-09 | $164.72M derived: sum of 2 quarters · filed 2025-02-27 | $253.63M derived: sum of 3 quarters · filed 2025-02-27 | $336.44M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2022-12-31 | $79.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $168.59M derived: sum of 2 quarters · filed 2025-02-27 | $251.41M derived: sum of 3 quarters · filed 2025-02-27 | $323.57M 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | $88.90M 10-Q · filed 2023-11-09 | $171.72M derived: sum of 2 quarters · filed 2023-11-09 | $243.88M 10-Q · filed 2023-11-09 | $319.39M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2022-06-30 | $82.81M 10-Q · filed 2023-08-09 | $154.98M 10-Q · filed 2023-08-09 | $230.49M derived: sum of 3 quarters · filed 2024-02-29 | $301.81M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2022-03-31 | $72.17M 10-Q · filed 2023-05-10 | $147.68M derived: sum of 2 quarters · filed 2024-02-29 | $219.00M derived: sum of 3 quarters · filed 2024-02-29 | $288.67M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2021-12-31 | $75.51M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $146.83M derived: sum of 2 quarters · filed 2024-02-29 | $216.50M derived: sum of 3 quarters · filed 2024-02-29 | $280.94M 10-K · filed 2024-02-29 | |||||
| 2021-09-30 | $71.32M 10-Q · filed 2022-11-09 | $140.99M derived: sum of 2 quarters · filed 2022-11-09 | $205.43M 10-Q · filed 2022-11-09 | $265.13M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2021-06-30 | $69.67M 10-Q · filed 2022-08-09 | $134.11M 10-Q · filed 2022-08-09 | $193.81M derived: sum of 3 quarters · filed 2023-03-01 | $248.84M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2021-03-31 | $64.44M 10-Q · filed 2022-05-10 | $124.14M derived: sum of 2 quarters · filed 2023-03-01 | $179.17M derived: sum of 3 quarters · filed 2023-03-01 | $230.34M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2020-12-31 | $59.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $114.73M derived: sum of 2 quarters · filed 2023-03-01 | $165.90M derived: sum of 3 quarters · filed 2023-03-01 | $224.28M 10-K · filed 2023-03-01 | $223.56M 10-K · filed 2021-03-16 | ||||
| 2020-09-30 | $55.03M 10-Q · filed 2021-11-09 | $54.85M 10-Q · filed 2020-11-09 | $106.20M derived: sum of 2 quarters · filed 2021-11-09 | $164.58M 10-Q · filed 2021-11-09 | $164.05M 10-Q · filed 2020-11-09 | $220.63M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $51.17M 10-Q · filed 2021-08-09 | $109.19M 10-Q · filed 2021-08-09 | $165.60M derived: sum of 3 quarters · filed 2022-03-01 | $219.00M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-03-31 | $58.02M 10-Q · filed 2021-05-11 | $114.43M derived: sum of 2 quarters · filed 2022-03-01 | $167.82M derived: sum of 3 quarters · filed 2022-03-01 | $220.65M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | $56.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $109.80M derived: sum of 2 quarters · filed 2022-03-01 | $162.62M derived: sum of 3 quarters · filed 2022-03-01 | $214.89M 10-K · filed 2022-03-01 | $214.49M 10-K · filed 2020-03-09 | ||||
| 2019-09-30 | $53.40M 10-Q · filed 2020-11-09 | $106.22M derived: sum of 2 quarters · filed 2020-11-09 | $158.48M 10-Q · filed 2020-11-09 | $209.05M derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2019-06-30 | $52.82M 10-Q · filed 2020-08-10 | $105.08M 10-Q · filed 2020-08-10 | $155.65M derived: sum of 3 quarters · filed 2021-03-16 | $197.02M derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2019-03-31 | $52.26M 10-Q · filed 2020-05-11 | $102.83M derived: sum of 2 quarters · filed 2021-03-16 | $144.19M derived: sum of 3 quarters · filed 2021-03-16 | $187.47M derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2018-12-31 | $50.57M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $91.93M derived: sum of 2 quarters · filed 2021-03-16 | $135.21M derived: sum of 3 quarters · filed 2021-03-16 | $176.20M 10-K · filed 2021-03-16 | |||||
| 2018-09-30 | $41.36M 10-Q · filed 2019-11-12 | $2.25M 10-Q · filed 2018-11-09 | $84.64M derived: sum of 2 quarters · filed 2019-11-12 | $125.63M 10-Q · filed 2019-11-12 | $4.35M 10-Q · filed 2018-11-09 | $126.93M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $43.28M 10-Q · filed 2019-08-09 | $942.53K 10-Q · filed 2018-08-07 | $84.27M 10-Q · filed 2019-08-09 | $2.10M 10-Q · filed 2018-08-07 | $85.56M derived: sum of 3 quarters · filed 2019-08-09 | $88.42M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $40.99M 10-Q · filed 2019-05-10 | $1.16M 10-Q · filed 2018-05-10 | $42.29M derived: sum of 2 quarters · filed 2019-05-10 | $45.14M derived: sum of 3 quarters · filed 2019-05-10 | $45.36M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $1.30M 10-K · filed 2018-03-14 | $4.15M derived: sum of 2 quarters · filed 2018-11-09 | $4.37M derived: sum of 3 quarters · filed 2018-11-09 | $142.78M 10-K · filed 2020-03-09 | $4.59M 10-K · filed 2018-03-14 | ||||
| 2017-09-30 | $2.85M 10-Q · filed 2018-11-09 | $3.07M derived: sum of 2 quarters · filed 2018-11-09 | $3.29M 10-Q · filed 2018-11-09 | $3.47M derived: sum of 4 quarters · filed 2018-11-09 | |||||
| 2017-06-30 | $221.81K 10-Q · filed 2018-08-07 | $440.46K 10-Q · filed 2018-08-07 | $618.61K derived: sum of 3 quarters · filed 2018-08-07 | $633.10K derived: sum of 4 quarters · filed 2018-08-07 | |||||
| 2017-03-31 | $218.65K 10-Q · filed 2018-05-10 | $396.80K derived: sum of 2 quarters · filed 2018-05-10 | $411.30K derived: sum of 3 quarters · filed 2018-05-10 | $411.80K derived: sum of 4 quarters · filed 2018-05-10 | |||||
| 2016-12-31 | $178.16K 10-K · filed 2018-03-14 | $192.65K derived: sum of 2 quarters · filed 2018-03-14 | $193.15K derived: sum of 3 quarters · filed 2018-03-14 | $99.31M 10-K · filed 2019-03-18 | $208.70K 10-K · filed 2017-03-28 | ||||
| 2016-09-30 | $14.49K 10-K · filed 2018-03-14 | $14.99K derived: sum of 2 quarters · filed 2018-03-14 | $30.54K 10-Q · filed 2017-11-14 | ||||||
| 2016-06-30 | $500.00 10-K · filed 2018-03-14 | $16.05K 10-Q · filed 2017-08-11 | |||||||
| 2016-03-31 | $15.55K 10-K · filed 2018-03-14 | ||||||||
| 2015-12-31 | $25.16K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |